WILMINGTON – The private biopharmaceutical startup NiKang Therapeutics announced Tuesday that it has signed a licensing agreement for one of its small-molecule therapy drugs in China, marking its second such commercial deal. NiKang struck the ...
WILMINGTON – The biopharmaceutical startup NiKang Therapeutics announced Wednesday that it has signed a second clinical trial collaboration with a biopharma firm for its small-molecule therapy drug in about a month. NiKang, which is based ...
WILMINGTON – The greater Wilmington area is attracting a burgeoning growth of life science firms, many of which are investigating potential cancer treatments. Incyte Corp. and Prelude Therapeutics are among the public companies grabbing headlines, ...
WILMINGTON – NiKang Therapeutics Inc., a biotech startup working out of the Delaware Innovation Space on the DuPont Experimental Station, recently announced that it has closed a $50 million Series B financing round. The company ...